I no longer feel desperate for the vitiligo to go. If anything, I now use my experience to support others. I meet people, ...

An expert discusses how early diagnosis of vitiligo is primarily important for limiting the area requiring repigmentation, ...

Global Vitiligo Treatment Market is valued at approximately USD 446.56 million in 2022 and is anticipated to grow with a healthy growth rate of more than 4.3% during the forecast period 2023-2030.

India has the dubious distinction of having the highest prevalence of vitiligo in the world, estimated at 8.8 per cent (as against the global prevalence of 1 per cent-2 per cent). Every year, over 1 ...

Vitiligo, an autoimmune skin condition causing milky-white patches, arises from melanocyte destruction. It's non-contagious, ...

People with autoimmune skin diseases had significantly better cancer survival outcomes than others. Survival benefits were ...

Incyte's new CEO, Bill Meury, signals a potential strategic pivot toward M&A, leveraging his biopharma acquisition experience ...

VYNE Therapeutics Inc. (Nasdaq: VYNE) ('VYNE” or the 'Company”), a clinical-stage biopharmaceutical company focused on developing differentiated therapies to treat chronic inflammatory and ...

The leading Chronic Urticaria Companies such as Synermore Biologics, Incyte Corporation, Jasper Therapeutics, Novartis, ...

Incyte could be a few month away from a second FDA approval for its Opzelura cream that would make it the first medical treatment to re-pigment the skin of people with vitiligo. The FDA has kicked ...

This healthcare company still has plenty of growth potential, but it’s been a rocky road for investors recently.